Diagnostic value of interleukin-6 and C-reactive protein on early onset bacterial infection in preterm neonates with respiratory distress

被引:1
|
作者
Rego, Maria Aparecida C. [1 ]
Martinez, Francisco Eulogio [1 ]
Elias, Jorge, Jr. [2 ]
Mussi-Pinhata, Marisa Marcia [1 ]
机构
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pediat, BR-14049900 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Radiol, BR-14049900 Ribeirao Preto, SP, Brazil
关键词
C-reactive protein; cytokine; early onset neonatal sepsis; interleukin-6; neonatal respiratory distress syndrome; neonatal sepsis; preterm infant; TUMOR-NECROSIS-FACTOR; IMMEDIATE POSTNATAL-PERIOD; FACTOR-ALPHA; ILLNESS SEVERITY; NEWBORN-INFANTS; PLASMA-LEVELS; SEPSIS; PROCALCITONIN; MARKERS; RECEPTORS;
D O I
10.1515/JPM.2010.071
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aims: To evaluate the C-reactive protein (CRP) and interleukin-6 (IL-6) as diagnostic tools for early onset infection in preterm infants with early respiratory distress (RD). Methods: CRP and IL-6 were quantified at identification of RD and 24 h after in 186 newborns. Effects of maternal hypertension, mode of delivery, Apgar score, birth weight, gestational age, mechanical ventilation, being small for gestational age (SGA), and the presence of infection were analyzed. Results: Forty-four infants were classified as infected, 42 as possibly infected, and 100 as uninfected. Serum levels of IL-6 (0 h), CRP (0 h), and CRP (24 h), but not IL-6 (24 h) were significantly higher in infected infants compared to the remaining groups. The best test for identification of infection was the combination of IL-6 (0 h) 36 pg/dL and/or CRP (24 h) 0.6 mg/dL, which yielded 93% sensitivity and 37% specificity. The presence of infection and vaginal delivery independently increased IL-6 (0 h), CRP (0 h) and CRP (24 h) levels. Being SGA also increased the CRP (24 h) levels. IL-6 (24 h) was independently increased by mechanical ventilation. Conclusions: The combination of IL-6 (0 h) and/or CRP (24 h) is helpful for excluding early onset infection in preterm infants with RD but the poor specificity limits its potential benefit as a diagnostic tool.
引用
收藏
页码:527 / 533
页数:7
相关论文
共 50 条
  • [31] Patterns of increases in interleukin-6 and C-reactive protein as predictors for white matter injury in preterm infants
    Inomata, Kei
    Mizobuchi, Masami
    Tanaka, Satoshi
    Iwatani, Sota
    Sakai, Hitomi
    Yoshimoto, Seiji
    Nakao, Hideto
    PEDIATRICS INTERNATIONAL, 2014, 56 (06) : 851 - 855
  • [32] Do Serum C-reactive Protein and Interleukin-6 Predict Kidney Scarring After Urinary Tract Infection?
    Miguel Rodriguez, Luis
    Robles, Belen
    Manuel Marugan, Jose
    Suarez, Angeles
    Garcia Ruiz de Morales, Jose Maria
    INDIAN JOURNAL OF PEDIATRICS, 2013, 80 (12) : 1002 - 1006
  • [33] Efficacy of new leukocyte parameters versus serum C-reactive protein, procalcitonin, and interleukin-6 in the diagnosis of neonatal sepsis
    Celik, H. Tolga
    Portakal, Oytun
    Yigit, Sule
    Hascelik, Gulsen
    Korkmaz, Ayse
    Yurdakok, Murat
    PEDIATRICS INTERNATIONAL, 2016, 58 (02) : 119 - 125
  • [34] Cord blood procalcitonin and Interleukin-6 are highly sensitive and specific in the prediction of early-onset sepsis in preterm infants
    Steinberger, Eva
    Hofer, Nora
    Resch, Bernhard
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2014, 74 (05) : 432 - 436
  • [35] Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6
    Garcia de Guadiana-Romualdo, Luis
    Espanol-Morales, Ignacio
    Cerezuela-Fuentes, Pablo
    Consuegra-Sanchez, Luciano
    Hernando-Holgado, Ana
    Esteban-Torrella, Patricia
    Jimenez-Santos, Enrique
    Viqueira-Gonzalez, Monserrat
    de Bejar-Almira, Africa
    Dolores Albaladejo-Oton, Maria
    SUPPORTIVE CARE IN CANCER, 2015, 23 (07) : 2175 - 2182
  • [36] Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6
    Luis García de Guadiana-Romualdo
    Ignacio Español-Morales
    Pablo Cerezuela-Fuentes
    Luciano Consuegra-Sánchez
    Ana Hernando-Holgado
    Patricia Esteban-Torrella
    Enrique Jiménez-Santos
    Monserrat Viqueira-González
    África de Béjar-Almira
    María Dolores Albaladejo-Otón
    Supportive Care in Cancer, 2015, 23 : 2175 - 2182
  • [37] Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the CardShock study
    Kataja, Anu
    Tarvasmaki, Tuukka
    Lassus, Johan
    Sionis, Alessandro
    Mebazaa, Alexandre
    Pulkki, Kari
    Banaszewski, Marek
    Carubelli, Valentina
    Hongisto, Mari
    Jankowska, Ewa
    Jurkko, Raija
    Jantti, Toni
    Kasztura, Monika
    Parissis, John
    Sabell, Tuija
    Silva-Cardoso, Jose
    Spinar, Jindrich
    Tolppanen, Heli
    Harjola, Veli-Pekka
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 322 : 191 - 196
  • [38] Procalcitonin and C-reactive protein as biomarkers for neonatal bacterial infection
    Quadir, Ashfaque F.
    Britton, Philip N.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2018, 54 (06) : 695 - 699
  • [39] Diagnostic performance of procalcitonin for bacterial infection in severe alcoholic hepatitis compared with C-reactive protein
    Kang, Min Kyu
    Lee, Yu Rim
    Park, Soo Young
    Seo, Kwang Il
    Lee, Sang Soo
    Kim, Byung Seok
    Song, Jeong Eun
    Yoon, Jun Sik
    Hong, Young Mi
    Yoon, Ki Tae
    Chung, Woo Jin
    Park, Seung Ha
    Kim, Eunju
    Jun, Kyung Ran
    Park, Jung Gil
    Baek, Yang-Hyun
    Heo, Nae-Yun
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [40] Assessment value of interleukin-6, procalcitonin, and C-reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective study
    Zheng, Haifeng
    Luo, Zimian
    Yi, Yafei
    Liu, Kang
    Huo, Zhongjun
    You, Yaqin
    Li, Hujiao
    Tang, Min
    CANCER MEDICINE, 2024, 13 (13):